Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis.

Bianca Rocca, Carlo Patrono, Joao Morais, Colin Baigent, Jean-Philippe Collet, Desmond Fitzgerald, Sigrun Halvorsen, Agneta Siegbahn, Robert F. Storey, Gemma Vilahur

Risultato della ricerca: Contributo in rivistaArticolo in rivista

80 Citazioni (Scopus)

Abstract

Antiplatelet drugs provide first-line antithrombotic therapy for the management of acute ischemic syndromes (both coronary and cerebrovascular) and for the prevention of their recurrence. Their role in the primary prevention of atherothrombosis remains controversial because of the uncertain balance of the potential benefits and risks when combined with other preventive strategies. The aim of this consensus document is to review the evidence for the efficacy and safety of antiplatelet drugs, and to provide practicing cardiologists with an updated instrument to guide their choice of the most appropriate antiplatelet strategy for the individual patient presenting with different clinical manifestations of coronary atherothrombosis, in light of comorbidities and/or interventional procedures.
Lingua originaleEnglish
pagine (da-a)1760-1776
Numero di pagine17
RivistaJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume70
Stato di pubblicazionePubblicato - 2017

Keywords

  • platelets, antithrombotics, atherothrombosis

Fingerprint

Entra nei temi di ricerca di 'Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis.'. Insieme formano una fingerprint unica.

Cita questo